POINT Biopharma Global Inc.

NasdaqCM:PNT Stock Report

Market Cap: US$1.3b

POINT Biopharma Global Future Growth

Future criteria checks 3/6

POINT Biopharma Global is forecast to grow earnings and revenue by 9.2% and 22.6% per annum respectively while EPS is expected to grow by 10.5% per annum.

Key information

9.2%

Earnings growth rate

10.5%

EPS growth rate

Biotechs earnings growth28.3%
Revenue growth rate22.6%
Future return on equityn/a
Analyst coverage

Good

Last updated27 Dec 2023

Recent future growth updates

Recent updates

POINT Biopharma Global Inc. (NASDAQ:PNT) Analysts Just Slashed This Year's Estimates

Aug 20
POINT Biopharma Global Inc. (NASDAQ:PNT) Analysts Just Slashed This Year's Estimates

We Think POINT Biopharma Global (NASDAQ:PNT) Can Easily Afford To Drive Business Growth

Feb 01
We Think POINT Biopharma Global (NASDAQ:PNT) Can Easily Afford To Drive Business Growth

A Look At The Fair Value Of POINT Biopharma Global Inc. (NASDAQ:PNT)

Oct 18
A Look At The Fair Value Of POINT Biopharma Global Inc. (NASDAQ:PNT)

Point Biopharma plummets on announcing common stock offering

Sep 13

POINT Biopharma Global GAAP EPS of -$0.27 misses by $0.05

Aug 12

Earnings and Revenue Growth Forecasts

NasdaqCM:PNT - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/2025159-432081104
12/31/202469-41-35-1357
12/31/202318-95-70-1028
9/30/20232449793112N/A
6/30/20232419797118N/A
3/31/202323698156172N/A
12/31/202222798171184N/A
9/30/2022N/A-79-78-65N/A
6/30/2022N/A-72-65-56N/A
3/31/2022N/A-56-54-44N/A
12/31/2021N/A-46-54-45N/A
9/30/2021N/A-37-48-38N/A
6/30/2021N/A-23-37-24N/A
3/31/2021N/A-18-29-19N/A
12/31/2020N/A-13-18-8N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: PNT's forecast earnings growth (9.2% per year) is above the savings rate (2.2%).

Earnings vs Market: PNT's earnings (9.2% per year) are forecast to grow slower than the US market (15.1% per year).

High Growth Earnings: PNT's earnings are forecast to grow, but not significantly.

Revenue vs Market: PNT's revenue (22.6% per year) is forecast to grow faster than the US market (8.1% per year).

High Growth Revenue: PNT's revenue (22.6% per year) is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if PNT's Return on Equity is forecast to be high in 3 years time

Discover growth companies

7D

1Y

7D

1Y

7D

1Y